Twelve leading research teams from around the world have been shortlisted for Cancer Grand Challenges’ fifth funding round, competing to win up to £20 million ($27 million) each to tackle cancer’s most formidable challenges. 

Launched in 2020 by Cancer Research UK and the US National Cancer Institute (NCI), Cancer Grand Challenges is a global research initiative aiming to tackle complex problems in cancer. The initiative has brought together more than 1,200 scientists to solve problems ranging from the rise of cancers in young adults to developing innovative therapies for aggressive childhood cancers that currently have few or no treatment options.  

Leading scientists involved in the initiative have warned that a lack of private-sector, philanthropic and industry investment could stall the pace of breakthroughs in cancer research. Those involved have backed projects such as Cancer Grand Challenges to continue cancer research, with the initiative already investing over £315 million ($424 million) in 16 international teams. 

This year’s call drew a record 227 applications from experts spanning cancer biology, immunology, neuroscience, computer science and beyond. With nearly 10 million cancer deaths globally each year and a projected 60% rise in diagnoses by 2040, experts stress that bold, well-funded collaboration is vital to sustain progress. 

Director of Cancer Grand Challenges, Dr David Scott, said: “The global scientific community responded with extraordinary enthusiasm to our latest challenges, submitting a record number of proposals that aim to drive breakthroughs that traditional research cannot achieve, from harnessing AI to reprogramming cancer cells.” 

“These shortlisted teams have the potential to transform our understanding of cancer, and the more research we fund, the more lives we can ultimately save. That’s why we’re looking for bold partners to take on cancer’s greatest challenges with us.”  

Cancer Grand Challenges has ‘already had an impact’ 

In December, the 12 teams shortlisted will present their innovative solutions to the prevention, detection and treatment of cancer to the Cancer Grand Challenges’ Scientific Committee, a panel of world-leading scientists. Winners will receive grants to bring their research to life, and drive progress against cancer’s greatest challenges. 

Of the 12 shortlisted teams, several will receive grants of up to £20 million. The winners will be selected by the Cancer Grand Challenges Scientific Committee, a panel of internationally renowned experts. Each winning team will take on one of the newly identified challenges — considered among the toughest in cancer research. 

Charles Swanton, Scientific Committee Chair of Cancer Grand Challenges and Cancer Research UK’s Chief Clinician, highlighted that the challenge has already had an impact in cancer research. 

“The Mutographs team discovered that many carcinogens don’t actually trigger DNA mutations,” he said, “and this has completely changed our understanding of how cancer begins and opened a new frontier in prevention.”

This year’s shortlisted teams include AI-powered projects, research into DNA damage patterns and investigations into why only some cells turn cancerous.
 

Winning teams selected from the shortlist of 12 will be announced in March 2026. 

 

Bruno Quinney, Content Team, DDW